The U.S. Food and Drug Administration (FDA) has developed a new program across public, academic and private sectors to combat the COVID-19 pandemic, the administration reported on Tuesday.
We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them on our Privacy Policy. If you continue to use this site, you consent to our use of cookies.